Sideroblastic anemia overview: Difference between revisions
| Line 6: | Line 6: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | |||
The anemia can be so severe that support with transfusion is required. These patients usually do not respond to [[erythropoietin]] therapy. Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of pyrodoxine. ([[vitamin B6]]) | |||
===Surgery=== | ===Surgery=== | ||
In severe cases, bone marrow transplant is also an option with limited information about the success rate. | In severe cases, bone marrow transplant is also an option with limited information about the success rate. | ||
Revision as of 17:11, 4 February 2013
|
Sideroblastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sideroblastic anemia overview On the Web |
|
American Roentgen Ray Society Images of Sideroblastic anemia overview |
|
Risk calculators and risk factors for Sideroblastic anemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Sideroblastic anemia is caused by the abnormal production of red blood cells as part of myelodysplastic syndrome, which can evolve into hematological malignancies (especially acute myelogenous leukemia). Thus, the body has iron available, but cannot incorporate it into hemoglobin.
Treatment
Medical Therapy
The anemia can be so severe that support with transfusion is required. These patients usually do not respond to erythropoietin therapy. Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of pyrodoxine. (vitamin B6)
Surgery
In severe cases, bone marrow transplant is also an option with limited information about the success rate.